NASDAQ

PharmaCyte Biotech, Inc. (PMCB)

♥ 638 Thanks from members

Live price chart, market sentiment, and community perspectives for PharmaCyte Biotech, Inc. (NASDAQ: PMCB).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: PharmaCyte Research TeamLeadership: Kenneth L. Waggoner (CEO)Leadership: Brian Dow (CFO)Holder: Institutional HoldersHolder: Retail InvestorsCell-in-a-Box TechnologyPancreatic Cancer Therapeutics#PMCB#PharmaCyte Biotech#Biotech Stock#NASDAQ#Cell Therapy